In vitro treatment of colorectal cancer cells with the AURKA inhibitor hesperidin showed various effects including enhancement of p21 function and restoration of GSK‐3β function, resulting in prevention of β‐catenin accumulation in the cell nucleus 15. The gene discussed is CDKN1A; the disease is colorectal cancer.